Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.

Bioengineered - 1 Dec 2021

Xu Zhipeng, Chen Hui, Sun Jin, Mao Weipu, Chen Shuqiu, Chen Ming

Abstract excerpt

Bladder cancer (BLCA) is one of the most common cancers worldwide with high recurrence rate. Hence, we intended to establish a recurrence-related long non-coding RNA (lncRNA) model of BLCA as a potential biomarker based on multi-omics analysis. Multi-omics data including copy number variation (CNV) data, mutation annotation files, RNA expression profiles and clinical data of The Cancer Genome Atlas (TCGA) BLCA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Data Mining
Share to DNA Copy Number Variations
Share to Genetic Loci

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Neoplasm Recurrence, Local

Share to RNA, Long Noncoding

Share to Tumor Microenvironment

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34738881
DOI: 10.1080/21655979.2021.2000122
PMCID: PMC8810060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.PMID 34738881Read ↗

An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancerSemantic proximity Read ↗

Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinomaSemantic proximity Read ↗

Long non-coding RNAs to predict postoperative recurrence in muscle-invasive bladder cancer and to develop a new molecular classification systemSemantic proximity Read ↗

Integrating transcriptomics, single-cell omics, and deep learning-based histopathological features to identify OLFML3 as in bladder cancerSemantic proximity Read ↗

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)Semantic proximity Read ↗

Integrated Analysis of lncRNA-associated ceRNA Network Identifies Prognostic lncRNAs in Bladder Cancer Based on Whole Transcriptome Sequencing and TCGA DatabaseSemantic proximity Read ↗

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancerSemantic proximity Read ↗

An Immune-Related lncRNA Model for Predicting Prognosis, Immune Landscape and Chemotherapeutic Response in Bladder CancerSemantic proximity Read ↗

Integrating Multi-dimensional RNA Sequencing to Construct a Prognostic Risk Model for Bladder CancerSemantic proximity Read ↗

Development and verification of immune-related long non-coding RNA prognostic signature in bladder cancerSemantic proximity Read ↗

Integrative multi-omics approach for stratification of tumor recurrence risk groups of Hepatocellular Carcinoma patientsSemantic proximity Read ↗

Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.